Loading clinical trials...
Loading clinical trials...
A Double-Blind, Placebo-Controlled Study of Acamprosate Added to Escitalopram and Behavioral Treatment in Major Depressive Disorder (MDD) With Comorbid Alcohol Abuse/Dependence
Conditions
Interventions
acamprosate
escitalopram
+2 more
Locations
1
United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Start Date
March 1, 2007
Primary Completion Date
May 1, 2010
Completion Date
May 1, 2010
Last Updated
July 9, 2012
NCT07115329
NCT06793397
NCT07025720
NCT06780917
NCT04480918
NCT07422519
Lead Sponsor
Massachusetts General Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions